Centrally-Authorised Procedure (CAP)

Another term for Centralised Procedure (CP). “An EU Procedure type in which the EMA (European Medicines Agency) reviews and approves the application on behalf of all European Union countries.
Certain drugs, such as biotech, HIV, cancer and diabetes, must be submitted as a Centralised Procedure.”


Take advantage of the knowledge and best practices gained from more than 20 years of research, innovation and development for the health and life sciences sectors.